Trial Talk

Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many people with different types of cancer. However, researchers are still unsure of the best way to give immunotherapy, which can come with unpredictable side effects. 

In this episode, Clinical Fellow Sophie Merrick discusses how the REFINE trial hopes to address this problem, by testing if giving immunotherapy less frequently can still treat the cancer effectively, whilst improving the quality of life for patients, reducing side effects and costs. 

For more information and to access the transcript: www.mrcctu.ucl.ac.uk/news/news-stories/2023/july/new-podcast-episode-the-refine-trial-how-can-we-improve-the-way-we-give-cancer-immunotherapy/

Date of episode recording: 2023-04-19
Duration: 00:16:57
Language of episode: English
Presenter: Berta Terre-Torras
Guests: Sophie Merrick
Producer: Berta Terre-Torras

What is Trial Talk?

The Trial Talk Podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We will get inside trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement is shaping our studies, and discover new ways to run smarter studies.